Dr. Aron Simkins is a hematology/medical oncology physician at Mount Sinai Medical Center.

Dr. Simkins earned his medical degree at Universidad Central de Venezuela School of Medicine and graduated with honors. He completed his internship and residency in internal medicine at the University of Texas Health Science Center at Houston and his clinical research at The University of Texas MD Anderson Cancer Center. He completed his hematology and medical oncology fellowship at The George Washington University School of Medicine & Health Sciences. During his fellowship, he also completed a graduate program in clinical and translational research at the same institution and did his stem cell transplant rotations at the National Cancer Institute (NCI).

In 2021, he was awarded the Conquer Cancer ASCO Foundation Merit Award for his achievements in clinical and translational research education.

He is a member of the American Society of Clinical Oncology, the Society of Hematologic Oncology, the European Society for Medical Oncology, and the American Society of Hematology.

Dr. Simkins has authored numerous publications in leading peer-reviewed journals in his field, including the Journal of Clinical Oncology – Precision Oncology, Blood, and Cancer. He has also presented on a variety of topics at national conferences, including leukemia, lymphoma, and stem cell transplants.

*This physician is employed by Mount Sinai Medical Center

Selected Publications and Research:

• Comparing outcomes for non-metastatic rectal cancer in academic vs. community centers: A propensity-matched analysis of the National Cancer Database. Horsey ML, Sparks AD, Simkins A, Kim G, Ng M, Obias VJ.Am J Surg. 2021 Nov;222(5):989-997. doi: 10.1016/j.amjsurg.2021.05.005. Epub 2021 May 14.PMID: 34024628
• Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000. Kantarjian HM, DiNardo CD, Nogueras-Gonzalez GM, Kadia TM, Jabbour E, Bueso-Ramos CE, O’Brien SM, Konopleva M, Jain NB, Daver NG, Shpall EJ, Champlin RE, Simkins A, Garcia-Manero G, Keating MJ, Huang X, Cortes JE, Pierce SA, Ravandi F, Freireich EJ. 2018 Jun 15;124(12):2534-2540. doi: 10.1002/cncr.31370. Epub 2018 Apr 12.PMID: 29645075
• Diamond-Blackfan Anemia Predisposing to Myelodysplastic Syndrome in Early Adulthood. Simkins A, Bannon SA, Khoury JD, Kanagal-Shamanna R, Foglesong JS, Alvarado Y, Borthakur G, DiNardo CD.JCO Precis Oncol. 2017 Nov;1:1-5. doi: 10.1200/PO.17.00112.PMID: 35172515 No abstract available.
• Tackling Burkitt when it’s back. Simkins A, Dunleavy K. 2020 Apr 2;135(14):1078-1080. doi: 10.1182/blood.2020005329. PMID: 32243518
• Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH.Hematol Oncol Stem Cell Ther. 2019 Jun;12(2):115-118. doi: 10.1016/j.hemonc.2017.09.001. Epub 2018 Jan 31.PMID: 29409729
• Impact of advanced clinical and translational research educational programs on oncology specialties and career development. Aron Simkins, Michael Lee, Wencesley A. Paez, Cecilia Arana Yi, Heidi E. Kosiorek, Michael Curtis, and Timur Mitin. Journal of Clinical Oncology2021 39:15_suppl, 11026-11026